跳至主要内容
临床试验/NL-OMON42472
NL-OMON42472尚未招募不适用

Cardiac Contractility Modulation (CCM) Therapy in Subjects with Medically Refractory Heart Failure: A Randomized Efficacy Study (*IMPULSE-HF*) - IMPULSE-HF

Impulse Dynamics Inc.0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • a) Baseline ejection fraction * 25% and *45% (as assessed by the site)
  • b) NYHA class II or III despite receiving optimal medical therapy for heart failure, stable for at least 30 days based on patient*s medical records (chronic, not transient, heart failure)
  • c) Baseline VO2,max * 9 and * 18.5 ml O2/Kg/min

排除标准

  • a) Potentially correctible cause of HF (valvular, congenital, or untreated ischemic heart disease)
  • b) Clinically significant angina pectoris
  • c) Hospitalization for HF requiring the use of inotropic support within 30 days of enrollment
  • d) PR interval greater than 375 ms
  • e) Permanent or long-standing persistent atrial fibrillation/flutter, or cardioversion within 30 days of enrollment.
  • f) Exercise tolerance limited by condition other than heart failure (e.g., angina, COPD, peripheral vascular disease, orthopedic or rheumatologic conditions) or unable to perform baseline stress testing
  • g) Scheduled for a CABG or a PTCA procedure, or CABG procedure within 90 days or a PTCA procedure within 30 days of enrollment.
  • h) Biventricular pacing system, or indication for Biventricular pacing system
  • i) Myocardial infarction within 90 days of enrollment.
  • j) Mechanical tricuspid or aortic valves.
  • k) Ventricular assist device
  • l) Prior heart transplant
  • m) Pregnant or planning to become pregnant during the study
  • n) Age below 18
  • o) Subject participating in another study, unrelated to CCM, at the same time (or within 30 days prior to enrollment to this study)
  • p) Subjects on dialysis

研究者

发起方
Impulse Dynamics Inc.

相似试验